[Current aspects of leprosy].
About 95% of individuals who come in contact with M. leprae do not develop overt disease. The clinical form of the disease correlates with the T-cell mediated immune response of the host rather the direct damage caused by bacilli. We review the current aspects of epidemiology, transmission, bacteriology, clinical features, reactions, diagnosis, chemotherapy and treatment of reactions.
Sticht-Groh
V
V
Deutsches Aussätzigen-Hilfswerk e.V., Armauer-Hansen-Institut, Würzburg.
Bretzel
G
G
D000818:Animals; D016516:CD4-CD8 Ratio; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage; D007918:Leprosy / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D015440:Leprosy, Lepromatous / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D015441:Leprosy, Tuberculoid / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology
D007917:Leprostatic Agents